Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells
Domenica Scordamaglia, Francesca Cirillo, Marianna Talia, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner
Francesca Giordano, Alessandro Paolì, Martina Forastiero, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis
Wenfeng Zhang, Jia Wang, Cun Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Modulation of M1 and M2 macrophage polarization by metformin: Implications for inflammatory diseases and malignant tumors
Sara Jafarzadeh, Maryam Nemati, Raziyeh Zandvakili, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114345-114345
Closed Access
Metformin and long non-coding RNAs in breast cancer
Morteza Gholami, Zeynab Nickhah Klashami, Pirooz Ebrahimi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients
Marianna Talia, Eugenio Cesario, Francesca Cirillo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway
Francesca Cirillo, Marianna Talia, Maria Francesca Santolla, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells
Francesca Cirillo, Asia Spinelli, Marianna Talia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Jing‐Xuan Xu, Qi-Long Zhu, Yu-Miao Bi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells
Marianna Talia, Francesca Cirillo, Asia Spinelli, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 7
Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance
Monta Brīvība, Laila Silamiķele, Ineta Kalniņa, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 7
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer
Marianna Talia, Francesca Cirillo, Domenica Scordamaglia, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Molecular docking analysis of imeglimin and its derivatives with estrogen receptor-alpha
Anitha Elango, Iyanar Kannan, Ramya Ravichandar, et al.
Bioinformation (2024) Vol. 20, Iss. 7, pp. 711-718
Closed Access
Metformina: uma nova perspectiva para o tratamento de desordens cancerígenas
Saulo Henrique Silva, Maria D.L. Oliveira, César A.S. Andrade, et al.
Brazilian Journal of Development (2023) Vol. 9, Iss. 8, pp. 23480-23495
Open Access | Times Cited: 1
Scientometric analysis of lipid metabolism in breast neoplasm: 2012–2021
Xiaobing Lin, Qiuping Yang, Daitian Zheng, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer
Maria Grazia Muoio, Michele Pellegrino, V. Rapicavoli, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access
Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers
Md. Imtiazul Kabir, Robin Kumar, Lakshmi Sai Pratyusha Bugata, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 284-328
Closed Access
Page 1

Scroll to top